Y Intercept Hong Kong Ltd acquired a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,650 shares of the company’s stock, valued at approximately $583,000.
A number of other institutional investors also recently made changes to their positions in the business. Mariner LLC boosted its stake in shares of National HealthCare by 0.9% during the 4th quarter. Mariner LLC now owns 6,839 shares of the company’s stock valued at $938,000 after buying an additional 59 shares during the last quarter. ProShare Advisors LLC raised its holdings in National HealthCare by 3.3% in the fourth quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock valued at $338,000 after acquiring an additional 78 shares in the last quarter. Corient Private Wealth LLC raised its holdings in National HealthCare by 3.3% in the fourth quarter. Corient Private Wealth LLC now owns 4,499 shares of the company’s stock valued at $617,000 after acquiring an additional 144 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in National HealthCare by 2.2% in the fourth quarter. State of Alaska Department of Revenue now owns 7,161 shares of the company’s stock valued at $981,000 after acquiring an additional 152 shares in the last quarter. Finally, Quarry LP boosted its stake in National HealthCare by 171.9% during the 3rd quarter. Quarry LP now owns 261 shares of the company’s stock valued at $32,000 after acquiring an additional 165 shares during the last quarter. 56.44% of the stock is owned by institutional investors and hedge funds.
National HealthCare Price Performance
National HealthCare stock opened at $207.87 on Tuesday. National HealthCare Corporation has a 12 month low of $93.54 and a 12 month high of $220.86. The company has a fifty day moving average price of $196.54 and a two-hundred day moving average price of $170.16. The company has a market cap of $3.25 billion, a PE ratio of 26.41 and a beta of 0.63.
National HealthCare Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 1.3%. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. The ex-dividend date is Tuesday, June 30th. National HealthCare’s dividend payout ratio (DPR) is currently 61.89%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Royal Bank Of Canada raised shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. Robert W. Baird raised shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets raised National HealthCare to a “hold” rating in a report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, National HealthCare presently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on National HealthCare
Insiders Place Their Bets
In other National HealthCare news, Director Lisa Piercey bought 949 shares of the business’s stock in a transaction on Monday, June 1st. The shares were purchased at an average price of $184.26 per share, with a total value of $174,862.74. Following the completion of the acquisition, the director directly owned 949 shares of the company’s stock, valued at approximately $174,862.74. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 13.92% of the stock is currently owned by company insiders.
National HealthCare Profile
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Further Reading
- Five stocks we like better than National HealthCare
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
